Skip to main content

Increasing Eye Diseases to Underpin the Demand for Advanced Ophthalmology Technologies

Home » Press Release » Increasing Eye Diseases to Underpin the Demand for Advanced Ophthalmology Technologies

May 17, 2022

Increasing Eye Diseases to Underpin the Demand for Advanced Ophthalmology Technologies

The global advanced ophthalmology technologies market is witnessing a continued surge during the forecast period 2019 to 2027, thanks to the latest technological developments.

The advanced ophthalmology technologies market is expected to witness significant growth, at a CAGR of 10.61% with a valuation of USD 14, 411.56mn as compared to its previous market value of USD 7,841.76mn in 2020.

Researchmoz sheds some light on market insights including market size, drivers, restraints, trends, opportunities, and competitive landscape.

The increasing cases of eye diseases such as cataracts, glaucoma, and other eye conditions are expected to drive the advanced ophthalmology technologies market.

Factors Driving and Restraining the Market

 The global advanced ophthalmology technologies market is surely projected to witness sizeable growth in the coming years. Some of the factors that will drive and restrain the market are as follows.

  • The increasing geriatric population is projected to expand the advanced ophthalmology technologies market during the forecast period.
  • The growing eye diseases irrespective of age are expected to surge the demand for advanced ophthalmology technologies.
  • The rising awareness and increasing initiatives by the government are paving the way for the demand for advanced ophthalmology technologies.
  • The increasing research and development in this sector are likely to owe to the growth of the market in the coming years.

Although several factors support the advanced ophthalmology technologies market, there are certainly some challenges that this market is likely to face during the forecast period.

  • The high cost of ophthalmology devices and surgeries is expected to hamper the growth of the advanced ophthalmology technologies market.

Restraint aside, the increasing need for timely diagnosis and early treatment is projected to expand the global advanced ophthalmology technologies market in the coming years.

Analyst’s Overview

The global advanced ophthalmology technologies market is certainly expected to experience considerable growth from 2019 to 2027, at a CAGR of 10.61% and an estimated market value of USD 14, 411.56mn by 2027.

The recent developments in advanced ophthalmology technologies for advanced-stage patients with macular eye disease are an incredible step, which may lead to humongous growth in the future.

Further, innovative products such as orbital tissue expander that treats eye diseases due to trauma and robot scanner that detects early-stage macular disease are proving to be a boon in advanced ophthalmology technologies, which further is expected to upsurge the market growth in coming years.

The diagnostic segment is anticipated to surge, owing to technological advancement and the availability of skilled ophthalmologists.

The hospital sector is anticipated to hold the dominance in the global advanced ophthalmology technologies, owing to an increase in surgeries.

Further, North America and Europe are expected to thrive, owing to the availability of advanced technology and a large patient pool, driving the global advanced ophthalmology technologies market towards a phenomenal growth during the forecast period.

Competitive Landscape

The global advanced ophthalmology technologies market is largely competitive due to the presence of key players in the market.

The key players are always focusing on innovative products by leveraging technology in order to expand their market presence, thus increasing their market share or profitability.

Some of the current market players in the global advanced ophthalmology technologies market include-

  • Johnson & Johnson Services
  • Ziemer Ophthalmic Systems Ltd
  • Bausch & Lomb Incorporated
  • Novartis AG
  • CooperVision
  • Alcon Vision LLC
  • Carl Zeiss Meditec AG
  • Nidek Co. Ltd
  • Topcon Corporation

Key Takeaways

  • The increasing life expectancy rate is paving the way for the global advanced ophthalmology technologies market.
  • The government’s increasing expenditure to initiate awareness about eyes or vision diseases is envisioned to drive the advanced ophthalmology technologies market.
  • Latest innovative products such as VisionCare receiving FDA approval are foreseeable to be expanding the advanced ophthalmology technologies market.
  • Hospitals with enhanced infrastructures and healthcare facilities are slated to expand the advanced ophthalmology technologies market during the forecast period.

Product/Type Disposition (Revenue in USD million)

Diagnostic

  • Optical Coherence Tomography Scanners
  • Ophthalmic Ultrasound Imaging Systems
  • Wavefront Aberrometers
  • Optical Biometry Systems
  • Corneal Topography Systems
  • Specular Microscopes
  • Others

Therapeutic

  • Ophthalmic Lasers
  • Surgical Devices

 End Users Dispositions (Revenue in USD million)

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centres
  • Others

Regional Disposition 

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa (MEA)

Media Contact

Please drop a mail to the Global PR Team for your queries

Contact Us

We Are Just A Click Away!

[email protected]
+1-518-621-2074